News
Hovione Technology acquires global rights to new pulmonary inhaler...
www.cphi-online.com
The Papillon DPI isa single-part, blister-based, reusable inhaler, suitable for both chronic and acute treatments.
Hovione Technology acquires rights to the Papillon DPI
www.oindpnews.com
Apr 15, · According to Hovione Technology, the company has acquired global development and commercialization rights to the Papillon multi-use dry powder inhaler from its inventor, Klaus-Dieter Beller. The blister-based DPI is reusable and formed from a single part, “enabling ultra-affordable drug therapies at global scale,” the company said.
Hovione Technology completes pilot scale manufacturing for Papillon...
www.oindpnews.com
Nov 19, · The company announced in April that it had acquired the rights to the DPI from its inventor, Klaus-Dieter Beller. The Papillon DPI, which is formed from a single plastic part and is reusable, can hold doses of up to 50 mg and can be used for carrier-based or carrier-free formulations.
sorted by relevance / date